How AI could change the economics of commercial pharma
Leaders from Lundbeck, EVERSANA and Sanofi examine what changing commercial costs could mean for growth, partnerships and patient services.
Key insights
AI could change the economics of commercial growth by helping manufacturers support more products and opportunities with existing resources. As AI changes the resources needed for commercial execution, manufacturers and agencies are reco…